The University of Chicago Header Logo

Connection

Gaurav Upadhyay to Cardiac Resynchronization Therapy

Back to Details
This is a "connection" page, showing publications Gaurav Upadhyay has written about Cardiac Resynchronization Therapy.
Gaurav Upadhyay
Connection Strength
13.211
Cardiac Resynchronization Therapy
  1. The evolution of conduction system pacing and gaps in understanding. Prog Cardiovasc Dis. 2025 Jul-Aug; 91:113-120.
    View in: PubMed
    Score: 0.815
  2. Clinical outcomes of conduction system pacing compared to biventricular pacing in patients with mid-range ejection fraction. J Interv Card Electrophysiol. 2025 Jan; 68(1):111-116.
    View in: PubMed
    Score: 0.768
  3. Physiologic Pacing Targeting the His Bundle and Left Bundle Branch: a Review of the Literature. Curr Cardiol Rep. 2022 08; 24(8):959-978.
    View in: PubMed
    Score: 0.660
  4. Population-Level Impact of the Guidelines Update on Patient Selection and Outcomes After Cardiac Resynchronization Therapy. JACC Clin Electrophysiol. 2022 05; 8(5):651-661.
    View in: PubMed
    Score: 0.651
  5. Left Bundle Branch Block: Characterization, Definitions, and Recent Insights into Conduction System Physiology. Card Electrophysiol Clin. 2021 12; 13(4):671-684.
    View in: PubMed
    Score: 0.636
  6. Bradyarrhythmias and Physiologic Pacing in the ICU. J Intensive Care Med. 2022 May; 37(5):595-610.
    View in: PubMed
    Score: 0.608
  7. Keeping pace with the competition: His bundle versus biventricular pacing in heart failure. Curr Opin Cardiol. 2020 05; 35(3):295-307.
    View in: PubMed
    Score: 0.570
  8. On-treatment comparison between corrective His bundle pacing and biventricular pacing for cardiac resynchronization: A secondary analysis of the His-SYNC Pilot Trial. Heart Rhythm. 2019 12; 16(12):1797-1807.
    View in: PubMed
    Score: 0.533
  9. His Corrective Pacing or Biventricular Pacing for Cardiac Resynchronization in Heart Failure. J Am Coll Cardiol. 2019 07 09; 74(1):157-159.
    View in: PubMed
    Score: 0.533
  10. His Bundle Pacing for Cardiac Resynchronization. Card Electrophysiol Clin. 2018 09; 10(3):511-517.
    View in: PubMed
    Score: 0.504
  11. Pushing and recognizing the limits of nonresponse to cardiac resynchronization therapy: A valuable "negative" trial. Heart Rhythm. 2018 06; 15(6):877-878.
    View in: PubMed
    Score: 0.488
  12. Right Ventricular Pacing and Cardiac Resynchronization Devices. Card Electrophysiol Clin. 2018 03; 10(1):31-42.
    View in: PubMed
    Score: 0.482
  13. Does Cardiac Resynchronization Therapy Benefit Patients with Non-Left Bundle Branch Block Prolonged QRS Patterns? Curr Cardiol Rep. 2017 10 24; 19(12):125.
    View in: PubMed
    Score: 0.479
  14. Selective versus non-selective his bundle pacing for cardiac resynchronization therapy. J Electrocardiol. 2017 Mar - Apr; 50(2):191-194.
    View in: PubMed
    Score: 0.446
  15. Cause of death and CRT device selection: striving for certitude? Eur Heart J. 2015 Nov 01; 36(41):2777-9.
    View in: PubMed
    Score: 0.414
  16. Assessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy. Heart Rhythm. 2015 Jun; 12(6):1201-8.
    View in: PubMed
    Score: 0.398
  17. Managing atrial fibrillation in the CRT patient: controversy or consensus? Heart Rhythm. 2012 Aug; 9(8 Suppl):S51-9.
    View in: PubMed
    Score: 0.327
  18. Making a splash? -Intrathoracic impedance and the prediction of arrhythmic events.-. Circ J. 2011; 75(11):2539-40.
    View in: PubMed
    Score: 0.314
  19. Optimal pace timing for left bundle branch area pacing with or without an additional LV lead: results from the CSPOT study. Europace. 2026 May 06; 28(5).
    View in: PubMed
    Score: 0.216
  20. Left bundle branch area pacing compared with biventricular pacing for cardiac resynchronization therapy in patients with left ventricular ejection fraction =50%: Results from the International Collaborative LBBAP Study (I-CLAS). Heart Rhythm. 2025 08; 22(8):2028-2037.
    View in: PubMed
    Score: 0.201
  21. Echocardiographic response from left bundle branch area pacing optimized cardiac resynchronization therapy (LOT-CRT) vs traditional CRT. Heart Rhythm. 2025 10; 22(10):2616-2624.
    View in: PubMed
    Score: 0.201
  22. Multicenter Hemodynamic Assessment of the LOT-CRT Strategy: When Does Combining Left Bundle Branch Pacing and Coronary Venous Pacing Enhance Resynchronization?: Primary Results of the CSPOT Study. Circ Arrhythm Electrophysiol. 2024 Nov; 17(11):e013059.
    View in: PubMed
    Score: 0.194
  23. Conduction system pacing compared with biventricular pacing for cardiac resynchronization therapy in patients with heart failure and mildly reduced left ventricular ejection fraction: Results from International Collaborative LBBAP Study (I-CLAS) Group. Heart Rhythm. 2025 06; 22(6):1512-1522.
    View in: PubMed
    Score: 0.193
  24. Cardiac Conduction System Pacing: A Comprehensive Update. JACC Clin Electrophysiol. 2023 11; 9(11):2358-2387.
    View in: PubMed
    Score: 0.179
  25. Left Bundle Branch Block: Characterization, Definitions, and Recent Insights into Conduction System Physiology. Cardiol Clin. 2023 Aug; 41(3):379-391.
    View in: PubMed
    Score: 0.178
  26. 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure. Heart Rhythm. 2023 09; 20(9):e17-e91.
    View in: PubMed
    Score: 0.176
  27. Rescue left bundle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: Results from International LBBAP Collaborative Study Group. Heart Rhythm. 2022 08; 19(8):1272-1280.
    View in: PubMed
    Score: 0.164
  28. Left ventricle and mitral valve reverse remodeling in response to cardiac resynchronization therapy in nonischemic cardiomyopathy. Echocardiography. 2020 10; 37(10):1557-1565.
    View in: PubMed
    Score: 0.146
  29. The effects of cardiac resynchronization therapy on left ventricular and mitral valve geometry and secondary mitral regurgitation in patients with left bundle branch block. Echocardiography. 2019 08; 36(8):1450-1458.
    View in: PubMed
    Score: 0.136
  30. Intracardiac Delineation of Septal Conduction in Left Bundle-Branch Block Patterns. Circulation. 2019 04 16; 139(16):1876-1888.
    View in: PubMed
    Score: 0.133
  31. Effects of cardiac resynchronization therapy after inferior myocardial infarction on secondary mitral regurgitation and mitral valve geometry. Pacing Clin Electrophysiol. 2018 02; 41(2):114-121.
    View in: PubMed
    Score: 0.122
  32. Arrhythmia care in a value-based environment: Past, present, and future: Developed and endorsed by the Heart Rhythm Society (HRS). Heart Rhythm. 2018 02; 15(2):e5-e15.
    View in: PubMed
    Score: 0.121
  33. Impact of cardiac resynchronization therapy on mitral valve apparatus geometry and clinical outcomes in patients with secondary mitral regurgitation. Echocardiography. 2017 Nov; 34(11):1561-1567.
    View in: PubMed
    Score: 0.119
  34. Renal Response in Patients with Chronic Kidney Disease Predicts Outcome Following Cardiac Resynchronization Therapy. Pacing Clin Electrophysiol. 2015 Oct; 38(10):1192-200.
    View in: PubMed
    Score: 0.103
  35. Progressive ventricular dysfunction among nonresponders to cardiac resynchronization therapy: baseline predictors and associated clinical outcomes. Heart Rhythm. 2014 Nov; 11(11):1991-8.
    View in: PubMed
    Score: 0.096
  36. Does prior valve surgery change outcome in patients treated with cardiac resynchronization therapy? J Cardiovasc Electrophysiol. 2014 Nov; 25(11):1206-13.
    View in: PubMed
    Score: 0.095
  37. Pre-capillary pulmonary hypertension and right ventricular dilation predict clinical outcome in cardiac resynchronization therapy. JACC Heart Fail. 2014 Jun; 2(3):230-7.
    View in: PubMed
    Score: 0.094
  38. Device-measured physical activity versus six-minute walk test as a predictor of reverse remodeling and outcome after cardiac resynchronization therapy for heart failure. Am J Cardiol. 2014 May 01; 113(9):1523-8.
    View in: PubMed
    Score: 0.093
  39. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2014 May; 25(5):507-513.
    View in: PubMed
    Score: 0.092
  40. Usefulness and consequences of cardiac resynchronization therapy in dialysis-dependent patients with heart failure. Am J Cardiol. 2013 Nov 15; 112(10):1625-31.
    View in: PubMed
    Score: 0.090
  41. The anatomic and electrical location of the left ventricular lead predicts ventricular arrhythmia in cardiac resynchronization therapy. Heart Rhythm. 2013 May; 10(5):668-75.
    View in: PubMed
    Score: 0.086
  42. Electrical delay in apically positioned left ventricular leads and clinical outcome after cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2013 Feb; 24(2):182-7.
    View in: PubMed
    Score: 0.084
  43. Usefulness of hemoglobin A(1c) to predict outcome after cardiac resynchronization therapy in patients with diabetes mellitus and heart failure. Am J Cardiol. 2012 Sep 01; 110(5):683-8.
    View in: PubMed
    Score: 0.082
  44. Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes. Eur Heart J. 2012 Sep; 33(17):2181-8.
    View in: PubMed
    Score: 0.082
  45. Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis of biventricular vs. right ventricular pacing mode. Eur J Heart Fail. 2012 Jun; 14(6):661-7.
    View in: PubMed
    Score: 0.081
  46. His Bundle Pacing. J Am Coll Cardiol. 2018 08 21; 72(8):927-947.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.